Related references
Note: Only part of the references are listed.Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis
Vladislav A. Korobeynikov et al.
NATURE MEDICINE (2022)
Value of systematic genetic screening of patients with amyotrophic lateral sclerosis
Stephanie R. Shepheard et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)
The Impact of Microbiota on the Pathogenesis of Amyotrophic Lateral Sclerosis and the Possible Benefits of Polyphenols. An Overview
Julia Casani-Cubel et al.
METABOLITES (2021)
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
John W. Day et al.
LANCET NEUROLOGY (2021)
Gene therapy for ALS: A review
Defne A. Amado et al.
MOLECULAR THERAPY (2021)
Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS
Mariana Bravo-Hernandez et al.
NATURE MEDICINE (2020)
CRISPR deletion of the C9ORF72 promoter in ALS/FTD patient motor neurons abolishes production of dipeptide repeat proteins and rescues neurodegeneration
Gopinath Krishnan et al.
ACTA NEUROPATHOLOGICA (2020)
C9orf72 suppresses systemic and neural inflammation induced by gut bacteria
Aaron Burberry et al.
NATURE (2020)
ALS Genetics: Gains, Losses, and Implications for Future Therapies
Garam Kim et al.
NEURON (2020)
Monoclonal full-length antibody against TAR DNA binding protein 43 reduces related proteinopathy in neurons
Silvia Pozzi et al.
JCI INSIGHT (2020)
Single chain variable fragment antibodies directed against SOD1 ameliorate disease in mutant SOD1 transgenic mice
Ghanashyam D. Ghadge et al.
NEUROBIOLOGY OF DISEASE (2019)
Potential roles of gut microbiome and metabolites in modulating ALS in mice
Eran Blacher et al.
NATURE (2019)
scAAV9-VEGF-165 inhibits neuroinflammatory responses and invasion of macrophages into the peripheral nervous system of ALS transgenic mice
Ying Wang et al.
BRAIN RESEARCH BULLETIN (2018)
Stress Granule Assembly Disrupts Nucleocytoplasmic Transport
Ke Zhang et al.
CELL (2018)
Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALS
Tommaso Iannitti et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis
Bastien Pare et al.
SCIENTIFIC REPORTS (2018)
An oligomer-specific antibody improved motor function and attenuated neuropathology in the SOD1-G93A transgenic mouse model of ALS
Quan-xiu Dong et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model
Maria Grazia Biferi et al.
MOLECULAR THERAPY (2017)
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Lindsay A. Becker et al.
NATURE (2017)
In vivo genome editing improves motor function and extends survival in a mouse model of ALS
Thomas Gaj et al.
SCIENCE ADVANCES (2017)
Antibodies inhibit transmission and aggregation of C9orf72 poly-GA dipeptide repeat proteins
Qihui Zhou et al.
EMBO MOLECULAR MEDICINE (2017)
Decoding ALS: from genes to mechanism
J. Paul Taylor et al.
NATURE (2016)
Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs
Jie Jiang et al.
NEURON (2016)
Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration
Clotilde Lagier-Tourenne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis
Melissa S. Rotunno et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
Elisa Majounie et al.
LANCET NEUROLOGY (2012)
Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis
Makoto Urushitani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Antisense oligonucleotide therapy for neurodegenerative disease
Richard A. Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Share Paper
